The 14 linked references in paper A. Andreychenko M., T. Mozhaeva A., А. Андрейченко М., Т. Можаева А. (2017) “Рецидивирование и локальное лимфогенное метастазирование меланомы конъюнктивы // Recurrence and local lymphogenic metastasis of conjunctival melanoma” / spz:neicon:ogsh:y:2017:i:1:p:26-30

  1. Shields C.L., Fasiuddin A.F., Mashayekhi A., Shields J.A. Conjunctival nevi: clinical features and natural course in 410 consecutive patients. Arch Ophtalmol 2004;122(2):167–75. DOI: 10.1001/archopht.122.2.167 PMID: 14769591
  2. Choi J., Kim M., Park H.S., Lee S.Y. Clinical follow-up of conjunctival malignant melanoma. Korean J Ophthalmol 2005;19(2):91–5. DOI: 10.3341/kjo.2005.19.2.91 PMID: 15988922
  3. Zembowicz A., Mandal R.V., Choopong P. Melanocytic lesions of the conjunctiva. Arch Pathol Lab Med 2010 Dec;134(12):1785–92. DOI: 10.1043/2009-0522-RAR.1 PMID: 21128776
  4. Lommatzsch P.K., Werschnik C. [Malignant conjunctival melanoma. Clinical review with recommendations for diagnosis, therapy and follow-up]. [Article in German] Klin Monbl Augenheilkd 2002;219(10):710–21. DOI: 10.1055/s-2002-35693 PMID: 12447715
  5. Harooni H., Schoenfield L.R., Singh A.D. Current appraisal of conjunctival melanocytic tumors: classification and treatment. Future Oncol 2011;7(3):435–46. DOI: 10.2217/fon.11.12 PMID: 21417906
  6. Triay E., Bergman L., Nilsson B. et al. Time trends in the incidence of conjunctival melanoma in Sweden. Br J Ophthalmol 2009;93(11):1524–8. DOI: 10.1136/bjo.2009.157933 PMID: 19628487
  7. Kim H.J., McCormick S.A., Nath S. et al. Melanocytic nevi of the tarsal conjunctiva: clinicopathologic case series with review of literature. Ophthal Plast Reconstr Surg 2010;26(6):438–42. DOI: 10.1097/IOP.0b013e3181d18a64 PMID: 20683369
  8. Shields C.L., Demirci H., Karatza E., Shields J.A. Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology 2004;111(9):1747–54. DOI: 10.1016/j.ophtha.2004.02.013 PMID: 15350332
  9. Yousef Y.A., Finger P.T. Predictive value of the seventh edition American Joint Committee on Cancer staging system for conjunctival melanoma. Arch Ophthalmol 2012;130(5):599–606. DOI: 10.1001/archophthalmol.2011.2566 PMID: 22652846
  10. Zimmermann P., Dietrich T., Bock F. et al. Tumour-associated lymphangiogenesis in conjunctival malignant melanoma Br J Ophthalmol 2009; 93(11):1529–34. DOI: 10.1136/bjo.2008.147355 PMID: 19628489
  11. Tuomaala S., Kivelä T. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy. Ophtalmology 2004;111(4):816–21. DOI: 10.1016/j.ophtha.2003.11.001 PMID: 15051218
  12. Bock F., Regenfuss B., Cursiefen C. [Antiangiogenic therapy at the ocular surface: when, what and why?]. [Article in German] Ophthalmologe 2011;108(3):230–6. DOI: 10.1007/s00347-010-2262-0 PMID: 21271256
  13. Heindl L.M., Hofmann-Rummelt C., Adler W. Tumor-associated lymphangiogenesis in the development of conjunctival melanoma. Invest Ophthalmol Vis Sci 2011;52(10):7074–83. DOI: 10.1167/iovs.11-7902 PMID: 21849428
  14. Heindl L.M., Hofmann-Rummelt C., Adler W. Prognostic significance of tumorassociated lymphangiogenesis in malignant melanomas of the conjunctiva. Ophthalmology 2011;118(12):2351–60. DOI: 10.1016/j.ophtha.2011.05.025 PMID: 21835473